Abstract:In this study, we not only optimized and improved the synthesis process of levobupivacaine hydrochloride (21) but also conducted a comprehensive exploration of critical industrial-scale production details, and a novel high-performance liquid chromatography (HPLC) analysis method was developed. Starting with the readily available and cost-effective (R,S)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (28) as the initial material and utilizing l-(–)-dibenzoyl tartaric acid (29) for chiral separation, and then through substitution and a salting reaction, levobupivacaine hydrochloride (21) was obtained with high purity (chemical purity of 99.90% and enantiomeric excess (ee) values of 99.30%). The total yield of the three steps was 45%. Structures of intermediates and the final product were confirmed using nuclear magnetic resonance (NMR) (1H NMR, 13C NMR), mass spectrometry (MS), and elemental analysis. The crystal structure of the final product was determined through differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and X-ray diffraction (XRD). Furthermore, we evaluated the risk of the substitution reaction using a reaction calorimeter and accelerating rate calorimetry (ARC). This process offers the advantages of simple operation, greenness, safety, controllable quality, and cost-effectiveness. It provides reliable technical support for the industrial-scale production of levobupivacaine hydrochloride (21), which is of significant importance in meeting clinical demands. Pilot-scale production has already been successfully completed by China National Medicines Guorui Pharmaceutical Co., Ltd., with a production scale of 20 kg.

Industry-Oriented Route Evaluation and Process Optimization for the Preparation of Brexpiprazole

The Preparation of 8-[4-[4-(2-pyrimidinyl)-1-piperaziny]butyl]-8-azaspiro[4,5] Decane-7,9-dione Hydrochloride

Development and validation of RP-HPLC method for estimation of brexpiprazole in its bulk and tablet dosage form using Quality by Design approach

A Novel Asymmetric Synthesis of Cis-(3r, 4R)-N-(tert-butoxycarbonyl)-4-methyl-3-(methylamino) Piperidine

Novel and facile process for the preparation of Brexpiprazole an antipsychotic drug

Synthesis of 3-Aminopyrrolidine and its N-alkylating Derivatives

Novel process for omeprazole synthesis

Synthesis of Tert-Butyl-4-methyl-3-oxopiperidine-1-carboxylate

Scalable Process of Spiro(cyclopropane)oxazepane Pyridine Carboxylic Acid Through Kulinkovich, Mitsunobu, and Pd-Catalyzed Intramolecular C–N Coupling

Development of a New Manufacturing Route for Benzoylphenylureas and Their Key Intermediates

Development of a Practical Biocatalytic Process for ( S )- N -Boc-3-hydroxypiperidine Synthesis

Process Development of a Novel Route to Rilpivirine Hydrochloride

Development of an Efficient and Scalable Biocatalytic Route to (3R)-3-aminoazepane: A Pharmaceutically Important Intermediate

The Improved Synthetic Route for the Intermediate of Pramipexole

Development of a Robust and Scalable Process for the Large-Scale Preparation of Vilazodone

Process Optimization on the Synthesis of Fungicide Azoxystrobin

Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation of a Reaction Mechanism

Study on Synthesis Process of 3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic Acid

The Optimization of the Synthesis Process and the Identification of Levobupivacaine Hydrochloride

Improved Synthesis and Impurity Control Strategy of Penehyclidine Hydrochloride

Development of an Efficient and Scalable Biocatalytic Route to (1S,4r)-8-hydroxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl Propionate Via Enantioselective Enzymatic Desymmetrization of a Prochiral Diester